Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study

Eli N. Deal; Scott T. Micek; Richard M. Reichley; David J. Ritchie

doi:10.1016/j.clinthera.2009.02.015

Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study

Eli N. Deal, Scott T. Micek, Richard M. Reichley, David J. Ritchie

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	299-310
Number of pages	12
Journal	Clinical Therapeutics
Volume	31
Issue number	2
DOIs	https://doi.org/10.1016/j.clinthera.2009.02.015
State	Published - Feb 2009
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Pharmacology (medical)

Keywords

cefepime
Citrobacter freundii
Enterobacter aerogenes
Enterobacter cloacae
Pseudomonas aeruginosa

Access to Document

10.1016/j.clinthera.2009.02.015

Cite this

Deal, E. N., Micek, S. T., Reichley, R. M., & Ritchie, D. J. (2009). Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study. Clinical Therapeutics, 31(2), 299-310. https://doi.org/10.1016/j.clinthera.2009.02.015

Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study. / Deal, Eli N.; Micek, Scott T.; Reichley, Richard M. et al.
In: Clinical Therapeutics, Vol. 31, No. 2, 02.2009, p. 299-310.

Research output: Contribution to journal › Article › peer-review

Deal, EN, Micek, ST, Reichley, RM & Ritchie, DJ 2009, 'Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study', Clinical Therapeutics, vol. 31, no. 2, pp. 299-310. https://doi.org/10.1016/j.clinthera.2009.02.015

@article{e3bb2624cf69401789c42fb89975a2ae,

title = "Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study",

keywords = "cefepime, Citrobacter freundii, Enterobacter aerogenes, Enterobacter cloacae, Pseudomonas aeruginosa",

author = "Deal, {Eli N.} and Micek, {Scott T.} and Reichley, {Richard M.} and Ritchie, {David J.}",

year = "2009",

month = feb,

doi = "10.1016/j.clinthera.2009.02.015",

language = "English",

volume = "31",

pages = "299--310",

journal = "Clinical Therapeutics",

issn = "0149-2918",

number = "2",

}

TY - JOUR

T1 - Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa

T2 - A single-center, open-label, prospective, observational study

AU - Deal, Eli N.

AU - Micek, Scott T.

AU - Reichley, Richard M.

AU - Ritchie, David J.

PY - 2009/2

Y1 - 2009/2

KW - cefepime

KW - Citrobacter freundii

KW - Enterobacter aerogenes

KW - Enterobacter cloacae

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=62549159984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549159984&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2009.02.015

DO - 10.1016/j.clinthera.2009.02.015

M3 - Article

C2 - 19302902

AN - SCOPUS:62549159984

SN - 0149-2918

VL - 31

SP - 299

EP - 310

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 2

ER -

Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this